Search | Market Research Reports® Inc.

0 items USD 0.00

Search

Did you mean: chronic lymphoma leukemia

Your search for "Chronic lymphocytic leukemia" gave back 1290 results.

Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021

Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...

Catalog:

Global Markets Direct

October 2021

Price: USD 2,500.00

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2018

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...

Catalog:

Global Markets Direct

May 2018

Price: USD 2,000.00

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2020

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...

Catalog:

Global Markets Direct

November 2020

Price: USD 2,500.00

B-Cell Chronic Lymphocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

B-Cell Chronic Lymphocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global...

Catalog:

Global Markets Direct

April 2022

Price: USD 2,000.00

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2019

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...

Catalog:

Global Markets Direct

November 2019

Price: USD 2,000.00

B-Cell Chronic Lymphocytic Leukemia (Oncology) - Drugs In Development, 2021

B-Cell Chronic Lymphocytic Leukemia (Oncology) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...

Catalog:

Global Markets Direct

July 2021

Price: USD 2,000.00

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2019

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...

Catalog:

Global Markets Direct

March 2019

Price: USD 2,000.00

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2018

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...

Catalog:

Global Markets Direct

February 2018

Price: USD 2,000.00

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2018

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...

Catalog:

Global Markets Direct

August 2018

Price: USD 2,000.00

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2020

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...

Catalog:

Global Markets Direct

February 2020

Price: USD 2,000.00

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2020

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...

Catalog:

Global Markets Direct

August 2020

Price: USD 2,000.00

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2020

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...

Catalog:

Global Markets Direct

May 2020

Price: USD 2,500.00

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2019

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...

Catalog:

Global Markets Direct

December 2019

Price: USD 2,000.00

Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global...

Catalog:

Global Markets Direct

October 2022

Price: USD 2,500.00

Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021

Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 Summary Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) -...

Catalog:

Global Markets Direct

April 2021

Price: USD 2,000.00

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

Latest Blog Posts

Stay Connected

© Copyright 2010-24 Market Research Reports, Inc.. All Rights Reserved. M Market Research Reports and the M Market Research Reports Logo are registered trademarks of Market Research Reports, Inc.

Disclaimer: Market Research Reports, Inc. has no affiliation to, and is not associated with any other website(s) or organization(s). We offer syndicated research reports (like country analysis, SWOT analysis, competitive intelligence, industry reports, company reports and market analysis & trends reports) and custom market research from our website MarketResearchReports.com only.

If you are looking for a market research solution for your research requirements, please begin your search using the search box on top of this page or use our chat system to speak to our market research consultants or directly write to us.